Clinical Trial Update: Serial Cardiac Magnetic Resonance Imaging (CMR) With Contrast Agents and Biomarker Analysis for the Detection of Cardiotoxicity Under Anthracycline-containing Cancer Therapy [NA]

View source ↗

Summary

This clinical trial update reports ongoing recruitment for a study using serial cardiac MRI with contrast agents and biomarker analysis to detect cardiotoxicity…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anthracycline-induced Cardiotoxicity
• Cardiotoxicity

Snippet

Sponsor: Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) | Conditions: Cardiotoxicity, Anthracycline-induced Cardiotoxicity | NA | Status: RECRUITING